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Abstract
Background: Upper limb paresis is one of the most frequent and persistent impairments following stroke. Only 12–
34% of stroke patients achieve full recovery of upper limb functioning, which seems to be required to habitually
use the affected arm in daily tasks. Although the recovery of upper limb functioning is most pronounced during
the first 4 weeks post stroke, there are few studies investigating the effect of rehabilitation during this critical time
window. The purpose of this trial is to determine the effect of electrical somatosensory stimulation (ESS) initiated in
the acute stroke phase on the recovery of upper limb functioning in a nonselected sample of stroke patients.
Methods/design: A sample of 102 patients with upper limb paresis of varying degrees of severity is assigned to
either the intervention or the control group using stratified random sampling. The intervention group receives ESS
plus usual rehabilitation and the control group receives sham ESS plus usual rehabilitation. The intervention is
applied as 1 h of ESS/sham ESS daily, followed by motor training of the affected upper limb. The ESS/sham ESS
treatment is initiated within 7 days from stroke onset and it is delivered during hospitalization, but no longer than
4 weeks post stroke. The primary outcome is hand dexterity assessed by the Box and Block Test; secondary
outcomes are the Fugl-Meyer Assessment, hand grip strength, pinch strength, perceptual threshold of touch,
degree of pain, and modified Rankin Scale score. Outcome measurements are conducted at baseline, post
intervention and at 6-month follow-up.
Discussion: Because of the wide inclusion criteria, we believe that the results can be generalized to the larger
population of patients with a first-ever stroke who present with an upper limb paresis of varying severity. On the
other hand, the sample size (n = 102) may preclude subgroup analyses in such a heterogeneous sample. The sham
ESS treatment totals a mere 2% of the active ESS treatment delivered to the intervention group per ESS session,
and we consider that this dose is too small to induce a treatment effect.
Trial registration: ClinicalTrials.gov, NCT02250365. Registered on 18 September 2014.
Keywords: Acute stroke, Upper extremity, Recovery of function, Electrical stimulation, Rehabilitation, Longitudinal
studies
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Background
Stroke is ranked as the third largest cause of disease bur-
den globally [1], causing substantial physical, psycho-
logical and financial demands on patients, families, and
societies at large [2–4]. Upper limb paresis is one of the
most frequent impairments following stroke and affects
48–77% of patients in the acute stroke phase [5–7].
Moreover, upper limb paresis has been identified as a
major obstacle to regaining independence in activities of
daily living (ADLs) [8]. In fact, only 12–34% of the pa-
tients achieve full functional recovery of the affected
upper limb at 6 months post stroke [9, 10]. This repre-
sents a considerable challenge since near complete func-
tional recovery is required to routinely involve the
affected upper limb in performing ADLs [11].
Recovery of upper limb functioning is typically pro-
nounced during the first month and subsequently levels
off by 6 months post stroke [12–14]. Regaining hand
dexterity (i.e., motor skills such as reaching, grasping,
gripping, moving and releasing objects) is often achieved
already within the first 4 weeks, implying that there may
be a critical time window for recovery of upper limb
functioning [9, 10] during which rehabilitation efforts
may maximize functional recovery. However, there are
few studies investigating the effect of motor rehabilita-
tion methods in the initial weeks after stroke.
Electrical stimulation (ES) is one of the methods that
have been used to facilitate recovery of upper limb func-
tioning following stroke. ES can induce a muscle con-
traction, or it can be a somatosensory stimulation below
the motor threshold [15]. The majority of studies using
ES have been conducted in chronic stroke and, there-
fore, it remains unknown to what extent ES applied in
the acute phase after stroke could affect the recovery of
upper limb functioning. Also, these investigations have
largely focused on ES that induces muscle contraction.
In healthy persons, the application of low-intensity ES
with no or small motor responses to peripheral hand
nerves [16–20], forearm muscles [21] or the whole hand
[22, 23] elicits an increase in the cortical excitability of
the representations that control the stimulated body
parts, which seems to outlast the stimulation period it-
self [18, 21, 23]. It has been hypothesized that increasing
the amount of somatosensory input may enhance the
motor recovery of patients following stroke [24]. Recent
data on acute, subacute and mostly chronic stroke pa-
tients suggest that a single 2-h session of ESS to the per-
ipheral hand nerves leads to transient improvement of
pinch force, movement kinematics and upper limb
motor skills required for ADL performance [25–31].
However, ESS was only used in conjunction with motor
training in one of these studies [29]. Interestingly, there
is some evidence that multiple sessions of ESS to the
peripheral hand nerves, in conjunction with motor
training, might improve motor skills of the paretic upper
limb in subacute [32, 33] and chronic stroke patients
[34], and, moreover, that these positive results seems to
be long lasting [34]. However, the effect of ESS in con-
junction with motor training has never been investigated
in acute stroke patients. It is noteworthy that ESS is be-
nign in nature, causes patients minimal discomfort and
adverse effects (itch and blushing), is relatively inexpen-
sive and can easily be incorporated into clinical practice
[35]. Therefore, it would be valuable to establish the ef-
fect of multiple sessions of ESS in conjunction with
motor training in the restoration of upper limb function-
ing in the acute stroke phase.
The purpose of the present trial is to investigate the
effect of multiple sessions of ESS treatment accompan-
ied by motor training on the recovery of the affected
upper limb following stroke. The ESS treatment is initi-
ated in the acute stroke phase and each ESS session is
immediately followed by motor training of the paretic
upper limb. Specifically, we wish to address the
following:
(1)Does ESS treatment: (a) reduce motor and sensory
impairments, (b) improve hand dexterity and (c)
reduce disability at the end of the intervention
period (short-term effect)?
(2)Are the changes that can be observed at the end of
the intervention period still present or improved at 6
months post stroke (long-term effect)?
Our hypothesis is that ESS treatment initiated in
the acute stroke phase will improve paretic upper
limb functioning as measured by the Box and Block
Test (BBT) (primary outcome measure) at 6 months
post stroke.
Methods/design
Trial design
This study is conducted as a single-blinded randomized
controlled trial with two arms and blinded endpoint ad-
judication. The intervention consists of ESS/sham ESS
treatment immediately followed by training of the af-
fected upper limb in addition to usual rehabilitation.
The ESS/sham ESS treatment is initiated within the first
7 days post stroke. The first 4 weeks post stroke seem to
be crucial for gaining maximal recovery of upper limb
functioning [9, 10]. Since it is not possible for us to con-
tinue the intervention after hospital discharge for finan-
cial and logistical reasons, we decided to investigate the
effect of our intervention during hospital stay (mean
hospital stay when designing this study: 21 days), but
no longer than 4 weeks post stroke. Outcome mea-
sures are assessed at three time points: (1) within the
first 7 days post stroke prior to intervention onset
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(baseline), (2) at hospital discharge or 4 weeks post stroke
(post-intervention) and (3) at 6 months post stroke
(follow-up), which is the time point where the recovery of
upper limb functioning is expected to level off [12–14].
Figure 1 shows the SPIRIT flow diagram of the trial.
Trial setting and participants
Trial participants are recruited among patients admitted
to the stroke unit (consisting of an acute unit and a
rehabilitation unit) at Bispebjerg Hospital, which is
one of the university hospitals in the Capital Region
of Denmark. The hospital currently serves a well-
defined urban catchment area with a population of
approximately 400,000 citizens from the Municipality
of Frederiksberg and the larger part of Municipality
of Copenhagen for stroke rehabilitation [36]. Except
for holiday periods and periods of recruitment of new
trial personnel, all patients consecutively admitted to
Fig. 1 SPIRIT flow diagram of the trial
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the stroke unit are assessed for eligibility by EG ac-
cording to following inclusion criteria:
1. Admission at the rehabilitation stroke unit
2. Diagnosis of acute stroke confirmed by magnetic
resonance imaging (MRI) or computed tomography
(CT) scan
3. Upper limb paresis as indicated by a subscore <66 on
the upper limb section of the Fugl-Meyer Assessment
(FMA) (A–D) (see “Outcome measures” section)
4. Residence in the hospital’s catchment area
5. Aged 18 years or older
Patients are not included if any of the following exclu-
sion criteria are present:
1. Contraindications to ESS (e.g., pacemaker in situ,
skin impairment) [37]
2. Inability to initiate the ESS treatment within 7 days
post stroke
3. Presence of cognitive dysfunctions or poor
communication skills in Danish that limits the
ability to provide informed consent
4. Severe prestroke disability as indicated by a modified
Rankin Scale (mRS) score = 5 (see “Outcome
measures” section)
5. Incomplete recovery of the affected upper limb after
a previous stroke
6. Participation in other biomedical intervention trials
within the last 3 months
The recruitment process takes place in several steps
which are presented in the flow diagram in Fig. 1.
We are collecting data on the following variables to
characterize the sample and to assess whether the
randomization is successful: (a) age, (b) gender, (c) pro-
fession, (d) living condition (i.e., married or living with
another person, alone), (e) risk factors for stroke: smok-
ing, alcohol consumption, prestroke nutritional habits,
prestroke physical activity level, weight, height, Body
Mass Index, waist circumference and other risk factors
for stroke (e.g., previous stroke, hypertension, hyperlip-
idemia, heart disease), (f ) type of stroke (i.e., hemorrhage
or infarction), (g) subtype of ischemic stroke [38], (h) se-
verity of stroke at baseline [39], (i) stroke acute treat-
ment, (j) affected upper limb, (k) dominant hand, (l)
medications, (m) complications during hospitalization,
(n) amount and content of upper limb training following
ESS and (o) amount and content of usual rehabilitation.
For further information, see Table 1.
Intervention
The ESS treatment is administered at the rehabilitation
stroke unit. Trained health care personnel who are not
involved in usual rehabilitation or outcome assessments
initiate the ESS treatment within 7 days post stroke ac-
cording to a standardized protocol. Both groups receive
1 h of daily ESS from Monday to Sunday throughout
their hospital stay, but for no longer than 4 weeks post
stroke. Cortical excitability in healthy persons increases
after 2 h of suprasensory ESS of peripheral hand nerves
at the wrist [18, 20], but it is sufficient with 30 min of
suprasensory ESS of the whole hand to induce increased
cortical excitability that lasts for 1 h after stimulation
has ended [22, 23]. When electrical stimulation is ap-
plied for a longer time period, it seems that cortical
Table 1 Time schedule of enrollment, intervention, assessments and responsible trial personnel
Trial procedure Time points during the course of the trial Responsible personnel Blinded to
group allocation?
Stroke onset – 7 days
post stroke
ESS treatment Post- intervention Hospital
discharge
6-month
follow-up
Assess eligibility X EG Not applicable
Present trial information for
potential participants
X EG/ESS personnel Not applicable
Collect informed consent X EG Not applicable
Group allocation X Administrative
personnel/SPM
No/no
Assess outcome X X X EG Yes
Collect sociodemographic data X X X EG Yes
Collect medical data X X X MS/EG/ESS personnel Yes/yes/no
Collect data on prestroke
nutritional habits and physical
activity
X EG/ESS personnel Yes/no
Collect data on upper limb
training and usual rehabilitation
X OTs or PTs at the stroke
unit and in the community
Yes
Collect data on ESS treatment,
including adverse events
X ESS personnel No
EG Emma Ghaziani, ESS electrical somatosensory stimulation, MS Mette Søndergaard, OT occupational therapist, PT physiotherapist, SPM S. Peter Magnusson
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excitability reaches a plateau after 45 min [19] and,
therefore, we decided to provide the ESS treatment for 1
h. A Cefar Compex Theta 500 electrical device specially
programmed to deliver ESS/sham ESS is used (DJO
Global Switzerland Sàrl, Ch. du Dévent, Z.I. Larges
Pièces A, 1024 Ecublens, Switzerland). Two sets of large
electrodes (Performance electrodes, 10 × 5 cm, One
Snap, DJO Nordic, AB., Murmansgatan 126, 212 25,
Malmö, Sweden) are placed on the affected arm as fol-
lows (see Fig. 2):
1. One set of electrodes on the upper arm – one
electrode on the front of the shoulder and the other
on the back of the shoulder, both of them covering
the lower part of the deltoid muscle
2. One set of electrodes on the forearm – one electrode
just distal to the elbow crease, centered on the
anterior aspect of the forearm; the other electrode just
proximal to the palm of the hand on the anterior and
radial aspect of the forearm
The stimulation level is determined individually for
each patient in the beginning of each ESS session. Half-
way into each ESS session, the stimulation level is ad-
justed, if necessary, in the intervention group, whereas
the participants in the control group receive a short visit
from the ESS personnel in order to ensure that the same
amount of attention is given to both groups.
The intervention group receives suprasensory ESS
delivered in a continuous mode (pulse width = 250 μs,
frequency = 10 Hz). Suprasensory ESS is defined as the
highest current amplitude that elicits paresthesia without
any discomfort, pain or visible muscle twitches. Sham ESS
is suprasensory ESS delivered in an intermittent mode
(active stimulation intervals of 3 s are delivered in loops of
2.5 min, pulse width = 250 μs, frequency = 10 Hz). In this
way the control group receives a total dose corresponding
to 2% of the amount of active ESS delivered to the inter-
vention group per ESS session, and we consider this dose
to be too small to induce treatment effect. Apart from
ESS/sham ESS during the hospital stay, no other electrical
therapy is permitted to the affected upper limb during the
6-month trial period. Delivering other types of interven-
tions (e.g., cognitive or motor training) is not allowed dur-
ing the ESS sessions. For further details, see the ESS
treatment protocol in Additional file 1.
The ESS/sham ESS treatment is followed by motor
training of the affected upper limb that takes place
within 30 min after cessation of the ESS. We expect that
brain excitability will be increased during this time inter-
val due to the ESS [18, 23]. To our knowledge, there is
no commonly acknowledged protocol for motor training
of upper limb paresis following stroke and, therefore, we
decided that the motor training would be provided in
accordance to the existing clinical practice at the depart-
ment which is currently not standardized. Thus, the
upper limb training consists of active, repetitive, task-
oriented practice. If the trial participant presents a se-
vere upper limb paresis with no or highly limited active
movements, the therapist in charge for the particular
training session decides which other intervention
methods will be employed. A task-oriented exercise bank
(see Additional file 2) is available for the physical (PTs)
and occupational therapists (OTs) delivering the upper
limb training. However, it is a requirement that trial par-
ticipants receive a minimum of 15 min of arm training
following each ESS session. Both groups are offered the
same upper limb training.
Usual rehabilitation is defined as PT and OT training
received by the stroke patients in the hospital as well as
at rehabilitation centers and, if relevant, at nursing
homes in the community during their 6-month trial
participation.
Outcome measures
The primary outcome measure is the Box and Block test
(BBT) at 6 months post stroke. The BBT assesses the
upper limb’s capacity to perform reaching, grasping,
moving and releasing objects unilaterally [40]. These
motor skills are essential components of performing
ADLs and, therefore, of relevance when evaluating
whether our intervention contributes to achieving the
ultimate goal of rehabilitation: independence in daily life.
Normative data are available for the healthy adult popu-
lation [40], and the instrument has been validated for
use in stroke patients [41].
Fig. 2 Placement of the electrodes
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The secondary outcomes measures are: (1) the upper
extremity section of the Fugl-Meyer Assessment (FMA-
UE) [42–44], (2) hand-grip strength [45], (3) palmar,
lateral and thumb-to-index pinch strength [45], (4) per-
ceptual threshold of touch [46, 47], (5) pain in the upper
limb during performance of the BBT using Numerical
Rating Scale-11 [48] and (6) the mRS score [49, 50]. The
FMA-UE, hand-grip strength, pinch strength, perceptual
threshold of touch, and degree of pain are ways to quan-
tify the level of motor and sensory impairments in the
upper limb. The mRS is a clinician-reported measure of
global disability which is widely used as an endpoint in
stroke trials.
All outcome measurements are carried out by EG.
Baseline assessments are performed at the stroke unit.
Post-intervention and 6-month follow-up assessments
are performed at the stroke unit, the patient’s home, or
the inpatient rehabilitation center or nursing home, de-
pending on the residence of the participant at the sched-
uled time.
Sample size estimation
Using a pretrial power analysis, we determined that a
minimum sample size of 37 patients was required for
correctly detecting a within-group improvement of 5.5
on the BBT, if such a difference truly exists, with a two-
sided significance level of 5% and a power of 80% [51].
The number of 5.5 blocks had previously been reported
as the smallest real difference between two measure-
ments for the affected upper limb [41]. Since the minim-
ally clinically important difference on BBT is, to our
knowledge, not established yet, we made the assumption
that the smallest real difference would be perceived by
stroke patients as being of clinical relevance for their
daily life. After adjusting for: (a) a case-fatality rate of 8%
as reported at 1 year post stroke in a Danish nationwide
population-based study [52] and (b) a 20% loss of partic-
ipants at follow-up for other reasons, we estimated that
51 participants were needed in each group [53]. Hence,
the total sample size is 102 participants.
Randomization
Participants are allocated sequentially to either the inter-
vention or the control group using a randomization list
constructed by block randomization with variable block
size. Randomization is furthermore stratified on: (a) sex
and (b) the ability to perform active finger extension at
baseline; active finger extension has shown to be a sim-
ple and reliable early predictor of recovery of upper limb
functioning in stroke patients [9, 54]. The randomization
sequence was generated with the random generator in
SAS. The randomization list is kept by administrative
personnel and concealed from the other project investi-
gators, with the exception of SPM. Allocations are
performed after baseline assessments by contacting the
administrative personnel who forwards the group alloca-
tion to the personnel responsible for ESS/sham ESS
treatment. SPM is occasionally involved in performance
of group allocation in the absence of the administrative
personnel.
Blinding
Although complete blinding of the participants to the
group allocation is impossible because of the nature of
the ESS treatment (i.e., participants can feel the stimula-
tion and are aware of whether it is delivered in continu-
ous or intermittent sham mode), participants are kept
unaware of how it is supposed to feel. The personnel
who apply ESS are not blinded to the group allocation,
and they also collect data from medical records that will
be used to characterize the sample. The therapists pro-
viding usual rehabilitation as well as other personnel in-
volved in usual patient care are blinded to the group
allocation. Investigators who perform outcome assess-
ments and data analysis are unaware of the group alloca-
tion, with the exception of the principal investigator
(SPM) who is involved in group allocation in the absence
of the administrative personnel, who are normally re-
sponsible for the group allocation and not involved in
any other trial procedures. For further details see
Table 1.
Statistical analysis
Background characteristics will be compared between
the intervention groups with t tests (continuous vari-
ables) or chi-squared tests (categorical variables). The
development of both primary and secondary outcome
variables will be analyzed in longitudinal models over the
stroke recovery trajectory (baseline, post-intervention and
6-month follow-up), and the difference of the outcomes
between the two intervention groups at each of the study
time points will be analyzed in multivariable linear re-
gression models. Analyses will be adjusted for the
stratification variables (sex and the ability to perform
finger extension). Possible differential attrition is ad-
justed for by weighting the outcomes that are avail-
able at each of the study time points with the inverse
of the probability of being present; these probabilities
are estimated in logistic regression models including
all background characteristics and outcomes at previ-
ous study time points. To account for this weighting
and for repeated observations on the same individual
generalized estimating equations (GEE) methods are
used to adjust the variance of the parameter estimates.
Analyses are performed with SAS version 9.4. The statis-
tical significance level is 5%.
Additional file 3 shows the SPIRIT Checklist [55, 56]
for this study protocol.
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Discussion
To our knowledge, this is the first trial investigating the
effect of multiple sessions of ESS treatment in the acute
stroke phase on the recovery of upper limb paresis. Sev-
eral studies have shown that the process of upper limb
recovery, and especially that of hand dexterity, is most
pronounced during the first 4 weeks post stroke after
which the recovery gradually levels off before reaching a
plateau around 6 months post stroke. Therefore, initi-
ation of rehabilitation in the early weeks post stroke may
be essential for achieving successful upper limb recovery
at the end of the rehabilitation process. Our trial intends
to evaluate the effect of ESS – a rehabilitation method
with the potential of applicability in clinical practice.
ESS is easy to administer, inexpensive, free of patient
discomfort and probably highly acceptable to frail pa-
tients in the early days post stroke.
Contrary to previous studies that primarily focused
on the stimulation of the peripheral hand nerves at
wrist level, we use two sets of large electrodes (see
“Intervention” section) to stimulate somatosensory recep-
tors in the shoulder, elbow and wrist regions. We believe
that the larger area covered may be beneficial, but because
we do not have a third trial arm receiving ESS at wrist
level only, we will not be able to identify the effect of in-
creasing the stimulation areas per se.
The eligibility criteria for participation in this trial are
very broad. Basically, we include all adult stroke patients
living in the hospital’s catchment area, except those with
remaining upper limb paresis from a previous stroke,
contraindications to ESS, severe prestroke disability or
inability to provide informed consent. Based on this
nonrestrictive participant selection, the results can be
generalized to the larger population of patients with a
first-ever stroke or successful recovery after a previous
stroke and who present an upper limb paresis of varying
degrees of severity. However, since our trial is not pow-
ered to perform subgroup analyses, we may encounter
challenges in detecting the effect of ESS in such a het-
erogeneous sample. The possibility of overlooking a
treatment effect on a specific subgroup of stroke patients
(type II error) is a limitation of the study.
Designing the control ESS treatment was challenging
since the intervention can be perceived by the trial par-
ticipants who may also interact with each other during
hospitalization. Since a completely inactive ESS treat-
ment gave rise to concerns about high dropout rates in
the control group, we designed a sham ESS treatment
with an extremely low treatment dose. It is unlikely that
the total amount of sham ESS treatment (1.2 min) is suf-
ficient to induce any training effects. However, we are
unable to verify this since we do not have a trial arm re-
ceiving completely inactive or no ESS. As a consequence,
our trial results can be biased towards an underestimation
of the effect of ESS treatment. It is noteworthy that both
the control and the intervention group receive the same
amount of attention from the personnel during the ESS
sessions. Although some participants might figure out
their group allocation, we hope that they would be moti-
vated to continue in the trial due to fact that they are
offered upper limb training in addition to the usual
rehabilitation.
Trial status
The recruitment of participants was initiated on 13
October 2014 and will continue until complete sample
size is achieved which is expected in March 2017. At the
submission time of this protocol article, patients are still
being recruited for the trial.
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